GSKGSK
13F holders, Q4 2024 (December 31)6holders −1
0new positions
1sold out
$33.82avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding GSK PLC (GSK) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holders were Kahn Brothers Group Inc. ($29.9M), Paradigm Asset Management Co. LLC ($44K) and PARK CIRCLE Co ($27K).
- Company
- GSK PLC
- Filed as
- GLAXOSMITHKLINE PLC (Q4 2024)
- CUSIP
- 37733W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $373K |
All 13F filers, Q3 2024 → Q4 2024: 183,454 shares sold, net −183,454 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Kahn Brothers Group Inc. | 6.50% | Reduce -16.4% | 884,708 | $29.9M |
| Paradigm Asset Management Co. LLC | 0.01% | Reduce -13.3% | 1,300 | $44K |
| PARK CIRCLE Co | 0.02% | No change | 800 | $27K |
| Asset Planning,Inc | 0.01% | — | 264 | $9K |
| Byrne Asset Management LLC | 0.00% | No change | 56 | $2K |
| Huntington National Bank | 0.00% | No change | 1 | $40 |
"% of holder's portfolio" is GSK's weight in each manager's 13F, not the share of GSK PLC the manager owns.